SCHEMBL12401973

SCHEMBL12401973

Cc1cc(C)c(-c2c(O)cc(C)oc2=O)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
HTT P42858 1/20 0.46
ANTXR2 P58335 1/20 0.42
MAOA P21397 1/20 0.41
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 5/20 0.39
MAPT P10636 5/20 0.39
GAA P10253 4/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPK1 P28482 1/20 0.39
ALOX12 P18054 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ELANE P08246 2/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
GLA P06280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9883889 0.87 ALDH1A1 (0.44) MEN1KMT2AHTTANTXR2MAOA
SCHEMBL13527164 0.86 ANTXR2 (0.40) MEN1KMT2AHTTANTXR2MAOA
SCHEMBL10309265 0.80 MAPT (0.38) MEN1KMT2AHTTANTXR2MAOA
SCHEMBL8316423 0.80 ALOX15 (0.41) MEN1KMT2AHTTMAOACA1
SCHEMBL15450054 0.79 TSHR (0.50) MEN1KMT2AANTXR2ALDH1A1MAPT
SCHEMBL17131537 0.77 ELANE (0.41) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL16485425 0.76 RXRA (0.43) HTTALDH1A1GAAMAPK1ELANE
SCHEMBL16485023 0.76 L3MBTL1 (0.40) HTTMAPTGAAL3MBTL1LMNA
SCHEMBL13002657 0.75 MAPT (0.36) MEN1KMT2AHTTANTXR2MAOA
SCHEMBL12269934 0.74 MAOB (0.44) MEN1KMT2AHTTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8334300-B2 C2-phenyl-substituted cyclic ketonols BAYER AKTIENGESELLSHAFT (DE) 2012-12-18 US disclosed
US-20110183849-A1 C2-PHENYL-SUBSTITUTED CYCLIC KETONOLS BAYER AKTIENGESELLSCHAFT (DE) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183849-A1 C2-PHENYL-SUBSTITUTED CYCLIC KETONOLS AKR1C3, PDHX, AKR1C2 MEN1 4025/4885KMT2A 844/4885HTT 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.